Editorial Commentary: Bioinductive Collagen Implants Yield Improved Retear Rates Compared With Other Types of Collagen Implants, Yet Exact Reasons Are Still Unknown.

Abstract

Biologic augmentation in arthroscopic rotator cuff repair has emerged as a key focus in the ongoing pursuit to enhance tendon healing and improve long-term outcomes. The recent randomized controlled trial of bovine bioinductive collagen implants in arthroscopic rotator cuff repair presents a significant reduction in retear rate. As biologic augmentation continues to evolve, future research should aim to define patient subgroups who are most likely to benefit from specific augmentation strategies, both biologically and economically. Moreover, we need an explanation as to what makes a bioinductive collagen implant produce better retear rate compared with other type of collagen implants.